At-Home High-Intensity Interval Training for Individuals with Paraplegia Following Spinal Cord Injury: A Case Series
Question
Is at-home arm-crank HIIT feasible, safe, and potentially effective for people with paraplegia after spinal cord injury?
Summary
Eight adults with paraplegia after spinal cord injury completed a 16-week at-home arm-crank HIIT case series. Adherence was high and peak power improved, but there was no control group, only five participants returned for in-person physiological testing, and several non-serious adverse events occurred.
Methodology
- Manual wheelchair users with chronic spinal cord injury below T6 and paraplegia
- 8 participants.
- Arm-cycle ergometry.
- Work intervals: 1 minute.
- Recovery: 2 minutes active recovery.
- Intensity: 80% HRR target; >=70% HRR acceptable.
- 24 minutes.
- 3 sessions/week.
- 16 weeks.
- Uncontrolled case series
- Adherence, Fitness, Peak power, and Safety were tracked.
Outcomes
Adherence
Adherence to the home program was high overall.
87 +/- 20%, range 38-100%.
Peak power
Peak power increased by about one quarter after 16 weeks.
About +26%, p=.027.
Safety
Four non-serious adverse events occurred, including shoulder soreness and sustained tachycardia.
Descriptive event reporting; tachycardia resolved within 30 minutes.
Insights
- Accessible HIIT needs modality-specific equipment logic, not only standing/bodyweight assumptions.
- Heart-rate targets may need wider acceptance bands in SCI because HR kinetics differ.
- Safety copy should include shoulder overuse and tachycardia stop rules for upper-body HIIT.
Limitations
- Small uncontrolled case series.
- Only five participants had complete in-person physiological testing due to COVID.
- Specialized equipment and clinical population.
- No validated HRR formula for SCI was established.
- No long-term follow-up.
Safety
- Two shoulder soreness events after sessions; one participant missed a week and symptoms resolved within a week.
- Two sustained tachycardia events likely related to the intervention resolved within 30 minutes.
- All adverse events were non-serious.